How Antibodies Eliminate Abnormal Proteins in Cancer Cells Cancer is a complex disease that arises from the uncontrolled growth and...
Bristol Myers Squibb, a leading global biopharmaceutical company, recently announced its acquisition of SystImmune for a whopping $800 million. This...
GSK’s Immuno-Oncology Treatment Receives Groundbreaking Approval in the EU In a groundbreaking development for cancer treatment, GlaxoSmithKline (GSK) has received...
Scientific Reports: Investigating the Powerful Antimicrobial and Anti-Lung Cancer Effects of Bacterial Polysaccharide Coated with Selenium Nanoparticles In recent years,...
Understanding Our Response to High or Low Oxygen Levels: A Comprehensive Analysis Oxygen is a vital element for all living...
Promising Results Found in Lung Cancer Treatment with Antibody-Immunotherapy Combination Lung cancer is one of the most common and deadliest...
Title: FDA Approves Expanded Use of Lilly Cancer Drug for Leukemia and Lymphoma Treatment Introduction In a significant development for...
The Food and Drug Administration (FDA) has recently granted priority review to the combination of Keytruda (pembrolizumab) and Padcev (enfortumab...
Arvinas Secures $350 Million Funding, Exonate’s Trial Achieves Positive Results, and Breakthrough Cancer Drugs Identified In recent news, the biotechnology...
A Promising Treatment Option for Small Cell Lung Cancer Patients Who Have Undergone Prior Treatment: Tarlatamab Small cell lung cancer...
FDA Issues Warning About Rare and Serious Reaction to Antiseizure Medications The Food and Drug Administration (FDA) has recently issued...
Title: The Increased Risk of Emphysema Associated with Smoking Tobacco and Weed Introduction: Emphysema is a chronic lung disease characterized...
Newly Discovered Advancement in COPD Treatment Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that affects millions of...
Findings from the MARIPOSA-2 Study: A Comprehensive Analysis of Advanced Lung Cancer Lung cancer is one of the most common...
